Charles-Joël Menkès

1.9k total citations
41 papers, 824 citations indexed

About

Charles-Joël Menkès is a scholar working on Rheumatology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Charles-Joël Menkès has authored 41 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 9 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Charles-Joël Menkès's work include Bone health and treatments (6 papers), Osteoarthritis Treatment and Mechanisms (6 papers) and Rheumatoid Arthritis Research and Therapies (6 papers). Charles-Joël Menkès is often cited by papers focused on Bone health and treatments (6 papers), Osteoarthritis Treatment and Mechanisms (6 papers) and Rheumatoid Arthritis Research and Therapies (6 papers). Charles-Joël Menkès collaborates with scholars based in France, United Kingdom and Belgium. Charles-Joël Menkès's co-authors include Serge Perrot, Mei Wu, Arthur C. Santora, Ronald Emkey, Philip D. Ross, Pierre J. Meunier, Henry G. Bone, Richard D. Wasnich, Richard P. Tonino and Jose Adolfo Rodriguez-Portales and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The American Journal of Medicine and Annals of the Rheumatic Diseases.

In The Last Decade

Charles-Joël Menkès

40 papers receiving 773 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles-Joël Menkès France 12 351 328 189 181 136 41 824
M Broggini Italy 14 256 0.7× 180 0.5× 138 0.7× 133 0.7× 56 0.4× 43 724
S.H. Ralston United Kingdom 18 490 1.4× 350 1.1× 105 0.6× 371 2.0× 190 1.4× 35 1.0k
S H Ralston United Kingdom 12 205 0.6× 285 0.9× 258 1.4× 110 0.6× 36 0.3× 23 756
Y. Boutsen Belgium 16 698 2.0× 485 1.5× 142 0.8× 329 1.8× 139 1.0× 40 1.2k
Paula Dakin United States 9 613 1.7× 561 1.7× 165 0.9× 378 2.1× 59 0.4× 34 970
G. M. Hall United Kingdom 10 412 1.2× 222 0.7× 441 2.3× 246 1.4× 102 0.8× 13 919
Laia Gifre Spain 16 270 0.8× 155 0.5× 94 0.5× 150 0.8× 146 1.1× 40 703
Firhaad Ismail United States 15 562 1.6× 505 1.5× 81 0.4× 340 1.9× 101 0.7× 23 1.1k
Julien Collette Belgium 16 149 0.4× 97 0.3× 199 1.1× 162 0.9× 112 0.8× 32 673
John Caminis United States 19 599 1.7× 298 0.9× 68 0.4× 443 2.4× 123 0.9× 32 1.1k

Countries citing papers authored by Charles-Joël Menkès

Since Specialization
Citations

This map shows the geographic impact of Charles-Joël Menkès's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles-Joël Menkès with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles-Joël Menkès more than expected).

Fields of papers citing papers by Charles-Joël Menkès

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles-Joël Menkès. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles-Joël Menkès. The network helps show where Charles-Joël Menkès may publish in the future.

Co-authorship network of co-authors of Charles-Joël Menkès

This figure shows the co-authorship network connecting the top 25 collaborators of Charles-Joël Menkès. A scholar is included among the top collaborators of Charles-Joël Menkès based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles-Joël Menkès. Charles-Joël Menkès is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dubousset, Jean, André Aurengo, D Bontoux, et al.. (2016). De l’usage des Rayons X en radiologie (diagnostique et interventionnelle), à l’exclusion de la radiothérapie. Rapport et recommandations.. Bulletin de l Académie Nationale de Médecine. 200(8-9). 1693–1707. 1 indexed citations
2.
Cervera, Pascale, et al.. (2013). Mucormycosis cerebral arteritis mimicking a flare in ANCA-associated vasculitis. The Lancet Infectious Diseases. 13(2). 182–182. 9 indexed citations
3.
Montastruc, Jean‐Louis, Jean‐Paul Tillement, D Bontoux, et al.. (2012). Pharmacovigilance : actualités et perspectives. Bulletin de l Académie Nationale de Médecine. 196(8). 1709–1720. 3 indexed citations
4.
Menkès, Charles-Joël. (2008). Lait et produits laitiers dans la prévention et le traitement des maladies par carence. Bulletin de l Académie Nationale de Médecine. 192(4). 739–747. 2 indexed citations
5.
Menkès, Charles-Joël & P Godeau. (2007). La fibromyalgie. Bulletin de l Académie Nationale de Médecine. 191(1). 143–148. 4 indexed citations
6.
Auquier, L, et al.. (2006). Ostéopathie et Chiropraxie. Bulletin de l Académie Nationale de Médecine. 190(1). 221–221. 1 indexed citations
7.
Tonino, Richard P., Pierre J. Meunier, Ronald Emkey, et al.. (2000). Skeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women1. The Journal of Clinical Endocrinology & Metabolism. 85(9). 3109–3115. 283 indexed citations
9.
Bossi, Philippe, Serge Perrot, N. Dupin, et al.. (1999). Human retrovirus-5 and Sjögren's syndrome. Clinical Microbiology and Infection. 5(2). 105–106. 1 indexed citations
10.
Reginster, Jean‐Yves, et al.. (1999). Prophylactic Use of Alfacalcidol in Corticosteroid-Induced Osteoporosis. Osteoporosis International. 9(1). 75–81. 88 indexed citations
11.
Veys, Eric, Charles-Joël Menkès, & Paul Emery. (1997). A randomized, double‐blind study comparing twenty‐four‐week treatment with recombinant interferon‐γ versus placebo in the treatment of rheumatoid arthritis. Arthritis & Rheumatism. 40(1). 62–68. 63 indexed citations
12.
Hernvann, Alain, et al.. (1996). Interleukin-1β-mediated glucose uptake by chondrocytes. Inhibition by cortisol. Osteoarthritis and Cartilage. 4(2). 139–142. 17 indexed citations
13.
Perrot, Serge & Charles-Joël Menkès. (1996). Nonpharmacological Approaches to Pain in Osteoarthritis. Drugs. 52(Supplement 3). 21–26. 17 indexed citations
14.
Hernvann, Alain, et al.. (1996). Action of anti-inflammatory drugs on interleukin-1β-mediated glucose uptake by synoviocytes. European Journal of Pharmacology. 314(1-2). 193–196. 4 indexed citations
15.
Hilliquin, Pascal, et al.. (1995). Production of PAF-acether by synovial fluid neutrophils in rheumatoid arthritis. Inflammation Research. 44(8). 313–316. 4 indexed citations
16.
Menkès, Charles-Joël. (1995). Editorial overview. Current Opinion in Rheumatology. 7(3). 235–236. 1 indexed citations
17.
Kahan, André & Charles-Joël Menkès. (1994). Gastrointestinal involvement in systemic sclerosis. Clinics in Dermatology. 12(2). 259–265. 7 indexed citations
18.
Menkès, Charles-Joël. (1994). Intraarticular treatment of osteoarthritis and guidelines to its assessment.. PubMed. 41. 74–6. 10 indexed citations
19.
Hilliquin, Pascal, et al.. (1992). Sweet's syndrome and monarthritis in a human immunodeficiency virus—positive patient. Arthritis & Rheumatism. 35(4). 484–486. 30 indexed citations
20.
Menkès, Charles-Joël. (1990). Metabolic bone disease. Current Opinion in Rheumatology. 2(1). 1–3. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026